|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.631
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.333
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.278
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.250
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.238
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.216
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.213
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.193
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.183
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.177
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.173
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.164
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.161
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.149
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.145
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.144
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.143
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.140
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.132
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.128
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.121
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.117
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.110
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.109
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.107
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.106
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.097
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.097
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.091
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.090
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.087
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.086
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.085
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.084
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.083
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.081
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.079
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.078
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.078
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.077
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.077
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.077
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.076
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.076
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.076
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.075
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.074
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.073
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.071
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.070
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.070
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.069
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.069
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.069
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.069
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.067
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.066
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.066
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.066
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.064
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.064
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.064
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.064
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.063
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.063
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.062
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.062
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.061
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.061
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.061
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.060
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.060
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.060
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.060
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.059
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.059
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.058
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.057
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.057
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.056
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.055
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.055
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.054
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.054
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.054
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.054
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.053
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.053
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.053
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.053
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.053
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.052
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.052
|
|
|
|
general adaptation syndrome
|
GO:0051866 |
2 |
0.051
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.050
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.050
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.050
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.050
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.049
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.049
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.048
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.048
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.047
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.046
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.046
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.046
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.045
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.045
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.045
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.045
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.045
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.044
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.044
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.044
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.044
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.044
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.043
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.043
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.043
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.043
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.043
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.043
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.042
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.042
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.042
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.042
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.042
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.042
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.041
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.041
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.040
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.040
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.040
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.039
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.039
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.039
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.039
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.039
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.038
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.038
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.038
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.038
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.037
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.037
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.037
|
|
|
|
detection of chemical stimulus involved in sensory perception of smell
|
GO:0050911 |
4 |
0.037
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.037
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.036
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.036
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.036
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.036
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.036
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.036
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.036
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.036
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.036
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.036
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.036
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.036
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.036
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.035
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.035
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.035
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.035
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.034
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.034
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.034
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.034
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.034
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.034
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.034
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.034
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.034
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.034
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.033
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.033
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.033
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.033
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.033
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.033
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.033
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.033
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.033
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.032
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.032
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.032
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.032
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.032
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.032
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.032
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.031
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.031
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.031
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.031
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.031
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.031
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.031
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.031
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.031
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.031
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.031
|
|
|
|
pons development
|
GO:0021548 |
13 |
0.031
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.031
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.031
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.030
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.030
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.030
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.030
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.030
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.030
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.030
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.030
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.030
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.030
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.029
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.029
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.029
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.029
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.029
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.029
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.029
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.028
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.028
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.028
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.028
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.028
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.028
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.028
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.028
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.028
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.027
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.027
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.027
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.027
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.027
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.027
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.027
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.027
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.027
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.027
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.027
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.027
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.027
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.027
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.027
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.026
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.026
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.026
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.026
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.026
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.026
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.026
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.026
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.026
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.026
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.025
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.025
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.025
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.025
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.025
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.025
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.025
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.025
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.025
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.025
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.025
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.025
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.024
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.024
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.024
|
|
|
|
anatomical structure regression
|
GO:0060033 |
9 |
0.024
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.024
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.024
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.024
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.024
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.024
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.024
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.024
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.024
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.024
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.024
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.024
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.024
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.024
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.023
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.023
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.023
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.023
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.023
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.023
|
|
|
|
catecholamine transport
|
GO:0051937 |
21 |
0.023
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.023
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.023
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.023
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.023
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.023
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.023
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.023
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.022
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.022
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.022
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.022
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.022
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.022
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.022
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.022
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.022
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.022
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.022
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.022
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.022
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.022
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.022
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.021
|
|
|
|
positive regulation of high voltage gated calcium channel activity
|
GO:1901843 |
1 |
0.021
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.021
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.021
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.021
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.021
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.021
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.021
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.021
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.021
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.021
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.021
|
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.021
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.021
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.021
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.020
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.020
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.020
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.020
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.020
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.020
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.020
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.020
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.020
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.020
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.020
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.020
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.020
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.020
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.020
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.020
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.020
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.020
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.020
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.020
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.020
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.019
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.019
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.019
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.019
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.019
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.019
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.019
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.019
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.019
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.019
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.019
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.019
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.019
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.019
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.019
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.019
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.019
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.019
|
|
|
|
fast calcium ion dependent exocytosis of neurotransmitter
|
GO:0098746 |
1 |
0.019
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.019
|
|
|
|
tachykinin receptor signaling pathway
|
GO:0007217 |
1 |
0.019
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.019
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.019
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.019
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.019
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.018
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.018
|
|
|
|
positive regulation of muscle contraction
|
GO:0045933 |
10 |
0.018
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.018
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.018
|
|
|
|
detection of chemical stimulus involved in sensory perception
|
GO:0050907 |
10 |
0.018
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.018
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.018
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.018
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.018
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.018
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.018
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.018
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.018
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.018
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.018
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.018
|
|
|
|
organ induction
|
GO:0001759 |
21 |
0.018
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.018
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.018
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.017
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.017
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.017
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.017
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.017
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.017
|
|
|
|
eating behavior
|
GO:0042755 |
15 |
0.017
|
|
|
|
regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010578 |
3 |
0.017
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.017
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.017
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.017
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.017
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.017
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.017
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.017
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.017
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.017
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.017
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.017
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.017
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.017
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.017
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.017
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.017
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.017
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.017
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.017
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.017
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.017
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.016
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.016
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.016
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.016
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.016
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.016
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.016
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.016
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.016
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.016
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.016
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.016
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.016
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.016
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.016
|
|
|
|
dicarboxylic acid transport
|
GO:0006835 |
29 |
0.016
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.016
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.016
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.016
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.016
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.016
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.016
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.016
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.016
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.016
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.016
|
|
|
|
corticosterone secretion
|
GO:0035934 |
3 |
0.016
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.016
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.016
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.016
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
24 |
0.016
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.016
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.016
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.016
|
|
|
|
positive regulation of catecholamine secretion
|
GO:0033605 |
2 |
0.016
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.016
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.016
|
|
|
|
positive regulation of fat cell proliferation
|
GO:0070346 |
1 |
0.016
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.015
|
|
|
|
general adaptation syndrome behavioral process
|
GO:0051867 |
1 |
0.015
|
|
|
|
rhombomere formation
|
GO:0021594 |
1 |
0.015
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.015
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.015
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.015
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.015
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.015
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.015
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.015
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.015
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.015
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.015
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.015
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.015
|
|
|
|
post anal tail morphogenesis
|
GO:0036342 |
23 |
0.015
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.015
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.015
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.015
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.015
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.015
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.015
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.015
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.015
|
|
|
|
bronchiole morphogenesis
|
GO:0060436 |
1 |
0.015
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.014
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.014
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.014
|
|
|
|
regulation of glutamate secretion
|
GO:0014048 |
3 |
0.014
|
|
|
|
detection of chemical stimulus
|
GO:0009593 |
16 |
0.014
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.014
|
|
